The Tanzania Neurology Clinical Trials market is projected to grow from $2.09 Mn in 2022 to $3.44 Mn by 2030, registering a CAGR of 6.4% during the forecast period of 2022 - 2030. The market will be driven by investment in infrastructure, resources, and training for healthcare professionals, as well as collaboration between local and international stakeholders. The market is segmented by phase, by study design & by indication. Some of the major players include Novartis AG, Sanofi S.A., AstraZeneca & GlaxoSmithKline.
The Tanzania Neurology Clinical Trials market is projected to grow from $2.09 Mn in 2022 to $3.44 Mn by 2030, registering a CAGR of 6.4% during the forecast period of 2022 - 2030. Tanzania's population also has among the world's lowest rates of access to health personnel. Approximately 60% of Tanzania's healthcare facilities are government-run, with the remainder being faith-based or private. As Tanzania advances towards universal healthcare, the government allotted $387.9 million for the health sector in 2020/2021, of which $155.5 million would be spent on development projects to assist the government in implementing its health-improving efforts. According to the World Health Organization (WHO), neurological illnesses account for around 10% of the country's overall disease burden. Tanzania performed one of the few known population-based stroke incidence studies from SSA and discovered an age-standardized incidence rate of up to 316 per 100,000 people.
Clinical trials are an essential part of medical research since they are used to evaluate the safety and efficacy of new drugs, medical equipment, or treatments. Clinical trials are conducted to determine that innovative therapies or drugs are safe, effective, and appropriate for use in patient care. Neurology clinical trials, in particular, focus on treatments for neurological ailments such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, stroke, and others. In Tanzania, neurology clinical trials are still very restricted in comparison to other countries, and the number of active studies in this sector is minimal. In recent years, however, there has been some success, with a few clinical trials in Tanzania evaluating novel treatments and therapies for neurological illnesses. There are several hospitals supportive of clinical trials such as Muhimbili National Hospital, Kilimanjaro Christian Medical Centre, Ifakara Health Institute, Bugando Medical Centre and others.
Market Growth Drivers
The high prevalence of neurological illnesses in Tanzania, including epilepsy, stroke, and neuro-infections, is one of the key drivers of growth. This has resulted in an urgent need for novel treatments and therapies, as well as improved access to current ones. Another driver of expansion is the growing interest in doing clinical research in Tanzania from both local and international partners. Tanzania has been recognised as a viable place for undertaking this sort of study due to a rising realisation of the need to create novel treatments and therapies that are especially suited to the requirements of patients in low-resource settings.
There are also various constraints impeding the expansion of neurology clinical trials in Tanzania. One of the most significant problems is the country's poor infrastructure and resources for performing clinical research, especially in rural regions. This has resulted in a concentration of clinical studies in cities, which may restrict the generalizability of the findings to the general population. Another challenge is a lack of skilled healthcare personnel, notably neurologists and other experts required to conduct and monitor clinical studies. As a result, there is a greater dependence on overseas partners, which might provide extra obstacles in terms of coordination, communication, and cultural differences.
The Tanzania Medicines and Medical Devices Authority (TMDA) and the Tanzania Commission for Science and Technology govern and supervise clinical research in Tanzania (COSTECH). In Tanzania, the TMDA is the regulatory body in charge of clinical trial authorization, monitoring, and inspections. In line with the TMMDAct and the CT-Regs, the TMDA gives approval for clinical trials to be undertaken in the nation.
1. Report Description of the Tanzania Neurology Clinical Trials Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Tanzania Neurology Clinical Trials Market Executive Summary
2.1 Tanzania Neurology Clinical Trials Market –Industry Snapshot & key buying criteria, 2022-2030
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of Tanzania Neurology Clinical Trials Market
3.1 Market Growth Drivers Analysis
3.2 Market Restrains Analysis
4. Tanzania Neurology Clinical Trials Market Segmentation
4.1 By Phase
4.1.1 Phase I
4.1.2 Phase II
4.1.3 Phase III
4.1.4 Phase IV
4.2 By Study Design Outlook
4.2.2 Parkinson's Disease (PD)
4.2.3 Huntington's Disease
4.2.5 Traumatic Brain Injury (TBI)
4.2.6 Amyotrophic Lateral Sclerosis (ALS)
4.2.7 Muscle regeneration
4.3 By Indication Outlook
4.3.3 Expanded Access
5. Tanzania Neurology Clinical Trials Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in Tanzania
8.2 Regulatory Framework in Tanzania
8.3 Pricing & Reimbursement Scenario in Tanzania Neurology Clinical Trials Market
9. Factors Driving Future Growth
9.1 New Trends and Development Tanzania Neurology Clinical Trials Market
9.2 Future Opportunities
10. Strategic Recommendations
By Phase (Revenue, USD Billion):
By Study Design Outlook (Revenue, USD Billion):
By Indication Outlook (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses